Alok A. Khorana, MD, on The Costs of VTE in Cancer Patients: Expert Perspective

2017 ASH Annual Meeting
Tweet this page

Alok A. Khorana, MD, of the Cleveland Clinic, discusses the prevalence of venous thromboembolism in cancer patients treated at U. S. emergency departments and associated costs, mortality, and hospital admissions in the United States (Abstract 219).

Advertisement

Advertisement



Advertisement